Salmeterol Xinafoate Patent Expiration
Salmeterol Xinafoate is Used for various medical conditions. It was first introduced by Glaxosmithkline
Salmeterol Xinafoate Patents
Given below is the list of patents protecting Salmeterol Xinafoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Serevent |
US5873360 (Pediatric) | Inhalation device |
Aug 23, 2016
(Expired) | Glaxosmithkline |
| Serevent | US5873360 | Inhalation device |
Feb 23, 2016
(Expired) | Glaxosmithkline |
Salmeterol Xinafoate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List